EP3880678
KRISTALLAFORM AF P2X3 METÝL (S)-2-((2-(2,6-DÍFLÚOR-4-(METÝLKARBAMÓÝL)FENÝL)-7-METÝLIMÍDASÓ[1,2-A]PÝRIDÍN-3-ÝL)METÝL)MORFOLÍN-4-KARBOXÝLAT
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
12.11.2019EP published:
7.5.2025EP application number:
19884611.5
EP translation filed:
30.5.2025Grant published:
15.6.2025EPO information:
European Patent Register
Max expiry date:
11.11.2039Expiry date:
11.11.2026Next due date:
30.11.2026
Title in English:
CRYSTALLINE FORMS OF P2X3 MODULATOR METHYL (S)-2-((2-(2,6-DIFLUORO-4-(METHYLCARBAMOYL )PHENYL)-7-METHYLIMIDAZO[1,2-A]PYRIDIN-3-YL)METHYL)MORPHOLINE-4-CARBOXYLATELanguage of the patent:
English
Timeline
Today
12.11.2019EP application
7.5.2025EP Publication
30.5.2025Translation submitted
15.6.2025Registration published
11.11.2026Expires
Owner
Name:
GlaxoSmithKline Intellectual Property (No.3) LimitedAddress:
GSK Medicines Research Centre Gunnels Wood Road, Stevenage SG1 2NY, GB
Inventor
Name:
GARCEAU, DenisAddress:
Laval, QC H7V 4A7, CA
Name:
WENSLOW, Robert M.Address:
Laval, QC H7V 4A7, CA
Name:
PAYZA, KemalAddress:
Laval, QC H7V 4A7, CA
Name:
CHAURET, NathalieAddress:
Laval, QC H7V 4A7, CA
Agent
Name:
Zacco Denmark A/SAddress:
Arne Jacobsens Allé 15, DK
Priority
Number:
201862760307 PDate:
13.11.2018Country:
US
Classification
Categories:
C07D 471/04, A61K 31/5377, A61P 11/14, A61P 13/00, A61P 15/00, A61P 17/04, A61P 29/00
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 11.11.2025
Expires: 11.11.2026
Payer: Árnason Faktor ehf.